Correction: Crosstalk between abnormal TSHR signaling activation and PTEN/PI3K in the dedifferentiation of thyroid cancer cells - Takeaways - MDSpire

Correction: Crosstalk between abnormal TSHR signaling activation and PTEN/PI3K in the dedifferentiation of thyroid cancer cells

  • By

  • Fang Feng

  • Huiqin Han

  • Shuqi Wu

  • Hui Wang

  • July 17, 2026

Share

  • 1

    The article discusses the interaction between TSHR signaling and PTEN/PI3K pathways in thyroid cancer cell dedifferentiation.

  • 2

    An erratum was issued for a mistake in Figure 1 of the original publication.

  • 3

    The error involved an outdated image of TPC-1 in Figure 1B.

  • 4

    The corrected Figure 1 has been provided in the erratum.

  • 5

    The original article was published in Frontiers in Oncology in 2021.

Original Source(s)

Correction: Crosstalk between abnormal TSHR signaling activation and PTEN/PI3K in the dedifferentiation of thyroid cancer cells

  • by Fang Feng, Huiqin Han, Shuqi Wu, Hui Wang

  • July 17, 2026

Related Content

Combined therapy strategies of immune checkpoint inhibitors in gynecologic oncology: progress and challenges

Molecular characteristics and advances in precision therapeutics for HR-positive and HER2-low breast cancer

Intravascular large B-cell lymphoma masked by multinodular goiter of the thyroid: a case report and diagnostic pitfall